Nebracetam - Misplaced Pages

This is an old revision of this page, as edited by BogBot (talk | contribs) at 09:53, 28 August 2011 (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 09:53, 28 August 2011 by BogBot (talk | contribs) (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Nebracetam" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message)

Pharmaceutical compound

Nebracetam
Clinical data


Routes of administration	Oral
ATC code	none
Legal status
Legal status	Unscheduled (US)
Identifiers
IUPAC name (RS)-4-(aminomethyl)-1-benzylpyrrolidin-2-one
CAS Number	97205-34-0
PubChem CID	65926
ChemSpider	59334
UNII	T30038QI8N
CompTox Dashboard (EPA)	DTXSID00869598
Chemical and physical data
Formula	C₁₂H₁₆N₂O
Molar mass	204.268 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES O=C2N(Cc1ccccc1)CC(C2)CN
InChI InChI=1S/C12H16N2O/c13-7-11-6-12(15)14(9-11)8-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2 Key:LCAFGJGYCUMTGS-UHFFFAOYSA-N
(verify)

Nebracetam is nootropic drug of the racetam family, and an antidepressant (M₁ acetylcholine receptor agonist).

See also